About our research:

Oslo Myeloma Center is the largest center for clinical myeloma research in the Nordics. 

Since 2015, 933 patients have been enrolled in 62 clinical studies in patients with smoldering multiple myeloma and multiple myeloma including newly diagnosed and relapsed/refractory patients in phase 1, 2, 3 and 4 studies.

Since 2015, 933 patients have been enrolled in 62 clinical studies in patients with smoldering multiple myeloma and multiple myeloma including newly diagnosed and relapsed/refractory patients in phase 1, 2, 3 and 4 studies.

Year Patient Number
2015 37
2016 67
2017 83
2018 98
2019 120
2020 83
2021 82
2022 105
2023 147
2024 110

Number of patients included in the different phases by end of 2024:

Phase 1 - 120 patients
Phase 2 - 305 patients
Phase 3 - 420 patients
Phase 4: 73 Patients

We maintain a comprehensive myeloma registry that includes both prospective and retrospective data. Additionally, our biobank collects materials that support translational research within our group.

 
Scroll to top